SCHEMBL21397101

SCHEMBL21397101

Cc1ccc2nc(-c3cc(-c4nc5ccc(C)cc5nc4-c4ccccc4)cc(-c4nc5ccc(C)cc5nc4-c4ccccc4)c3)c(-c3ccccc3)nc2c1

nearest known ligand 0.93

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.93
KDM4E B2RXH2 6/20 0.93
L3MBTL1 Q9Y468 3/20 0.93
TDP1 Q9NUW8 3/20 0.67
NQO2 P16083 1/20 0.62
KMT2A Q03164 2/20 0.58
ATM Q13315 1/20 0.58
TLR9 Q9NR96 1/20 0.58
MAPT P10636 4/20 0.54
LMNA P02545 4/20 0.54
RAB9A P51151 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
HPGD P15428 4/20 0.53
GAA P10253 2/20 0.53
NPC1 O15118 2/20 0.53
DHODH Q02127 1/20 0.50
PSMB5 P28074 1/20 0.49
PDE10A Q9Y233 1/20 0.49
MEN1 O00255 1/20 0.47
GPR55 Q9Y2T6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31415566 0.96 KDM4E (1.00) ALDH1A1KDM4EL3MBTL1TDP1NQO2
SCHEMBL31070206 0.96 KDM4E (1.00) ALDH1A1KDM4EL3MBTL1TDP1NQO2
SCHEMBL31070213 0.96 KDM4E (1.00) ALDH1A1KDM4EL3MBTL1TDP1NQO2
SCHEMBL1104817 0.96 KDM4E (1.00) ALDH1A1KDM4EL3MBTL1TDP1NQO2
SCHEMBL825060 0.94 KDM4E (0.96) ALDH1A1KDM4EL3MBTL1TDP1NQO2
SCHEMBL12553477 0.94 KDM4E (0.96) ALDH1A1KDM4EL3MBTL1TDP1NQO2
SCHEMBL18083001 0.93 ALDH1A1 (0.93) ALDH1A1KDM4EL3MBTL1TDP1NQO2
SCHEMBL13017481 0.87 KDM4E (0.83) ALDH1A1KDM4EL3MBTL1TDP1NQO2
SCHEMBL16687605 0.87 KDM4E (0.83) ALDH1A1KDM4EL3MBTL1TDP1NQO2
SCHEMBL12352239 0.87 KDM4E (0.69) ALDH1A1KDM4EL3MBTL1TDP1NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190292181-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 ALDH1A1 242/4885KDM4E 4364/4885L3MBTL1 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.